IL6 and COVID-19: In addition, certain biomarkers, especially interleukin-6 (IL-6), serum ferritin, and serum amyloid A (SAA) released during an immune response or “cytokine storm”, can be used as adjunct indicators for COVID-19 diagnosis, particularly for symptomatic patients, but show false negative results in conventional and “gold-standard” detection methods.